Pancreatic Guidewire-Assisted Fistulotomy Boosts Success in Difficult Biliary Cannulation: Study

Written By :  Aashi verma
Published On 2026-07-21 15:00 GMT   |   Update On 2026-07-22 09:31 GMT

A recent study published in the Indian Journal of Gastroenterology in May 2025 highlights a remarkable 93.8% success rate using pancreatic guidewire-assisted fistulotomy (PGAF) to navigate difficult biliary cannulations. This advanced rescue technique proved significantly superior and just as safe as conventional methods, which achieved only an 81.4% success rate.

Difficult biliary cannulation, particularly when compounded by the frustrating complication of unintentional pancreatic duct (PD) access, remains a formidable and potentially high-risk challenge even for the most seasoned endoscopic practitioners. Recognizing this critical clinical gap and the necessity for optimized salvage protocols, lead investigator Amir Sadeghi and an expert research team designed a rigorous prospective trial to meticulously evaluate the comparative safety and overall efficacy of two distinct advanced rescue methods: transpancreatic biliary sphincterotomy (TPBS) alongside the aforementioned fistulotomy approach.

Therefore, in the prospective, randomized, single-center clinical trial, out of 730 screened individuals, 194 patients experiencing difficult biliary access were randomized into two equal groups of 97 to compare successful cannulation rates. The study also monitored the patients for any procedure-related adverse events.

Key Clinical Findings of the Study Includes:

• Superior Cannulation Outcomes: The study demonstrated that the fistulotomy approach achieved a significantly higher biliary access success rate of 93.8% (91 patients) compared to the 81.4% (79 patients) success rate observed with the sphincterotomy technique. (p=0.01).

• Identified Failure Predictors: Research revealed that utilizing the sphincterotomy technique and possessing a normal common bile duct (CBD) diameter were both independently associated with an increased likelihood of unsuccessful cannulation.

• Comparable Safety Profiles: Analysis indicated that both advanced rescue techniques maintained remarkably similar safety profiles, with no statistically significant differences observed regarding overall adverse events (p=0.31).

• Specific Complication Rates: Evidence showed that post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis occurred in 8.2% of the fistulotomy group and 4.1% of the sphincterotomy group, while post-procedural bleeding was exceptionally rare, noted in 0% and 2.1% of the patients, respectively.

The results suggest that for adult patients actively facing the anatomical hurdles of difficult biliary cannulation accompanied by inadvertent PD access, proactively deploying the fistulotomy rescue method delivers a significantly enhanced procedural success probability of 93.8% without imposing any additional generalized risk of procedure-related complications.

Thus, the study concludes that practicing endoscopists should consider gradually incorporating the guidewire-assisted fistulotomy approach as their preferred, frontline rescue intervention over traditional sphincterotomy when standard double-guidewire salvage techniques ultimately fail during complex biliary procedures.

While the inherent single-center design of this investigation gently suggests a natural need for subsequent, broader multicenter evaluations to fully confirm and generalize these promising outcomes, the current evidence undeniably provides a highly valuable, evidence-based foundation for refining advanced endoscopic rescue strategies worldwide.

Reference

Sadeghi, A., Arabpour, E., Rastegar, R., Hosseinzadeh, E., Mozafari Komesh Tape, P., & Zali, M. R. (2025). Pancreatic guidewire–assisted fistulotomy versus transpancreatic biliary sphincterotomy in difficult biliary cannulation with unintentional pancreatic duct cannulation: A randomized clinical trial. Indian Journal of Gastroenterology, 44, 862–871.

Tags:    
Article Source : Indian Journal of Gastroenterology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News